Sanofi forges ahead with active ingredients spin-off-sources - Reuters

Sanofi forges ahead with active ingredients spin-off-sources - Reuters

More reads

• UK biotech firm skyrockets 552% after drug lowers odds of serious COVID-19 symptoms. (Business Insider)
• Two lawmakers own large sums of stock in vaccine makers set to testify before their committee. (STAT Plus)
• Ex-Sanofi Genzyme chief David Meeker hops to a new biotech CEO post. (Endpoints)
• Sanofi forges ahead with active ingredients spin-off. (Reuters)